Research & Development
Finding innovative solutions for serious medical problems is what being a healthcare company is about. Roche’s research and development efforts aim to enable healthcare to be tailored more closely to patients’ needs.
As both a diagnostics and a pharmaceuticals company, Roche is ideally placed to contribute to progress towards more personalised healthcare, opening up new ways to prevent, diagnose and treat illness.
In 2016, Roche invested CHF 9.9 billion in research and development worldwide, including over AUD $37 million (AUD) in pharmaceuticals in Australia. Requests for investigator initiated studies support may be submitted by clicking here.